TipRanks
Go Ultimate55% OFF

Madrigal Pharmaceuticals (MDGL) Revenue

Madrigal Pharmaceuticals Revenue

Madrigal Pharmaceuticals had a revenue of 364.25M in the quarter ending Jun 30, 2026, with 17.00%. This bring the company's revenue in the last twelve months to 1.28B, Increased 13.37%. In the fiscal year ending Dec 31, 2025, Madrigal Pharmaceuticals had annual revenue of 958.40M with 432.05% growth.

Revenue (ttm)
1.28B
Revenue Growth
149.04%
P/S Ratio
10.37
Revenue/Employee
$1,047,435
Employees
915
Market Cap
$9.94B

Revenue Chart

Madrigal Pharmaceuticals Revenue - Annual

0250M500M750M1B1.25B180.13M958.40M201720182019202020212022202320242025
Revenue History
Download to Excel
MDGL revenue history
Fiscal End DateRevenueChangeGrowth
Dec 31, 2025958.40M778.27M432.05%
Dec 31, 2024180.13M180.13M―
Dec 31, 20230.000.00―
Dec 31, 20220.000.00―
Dec 31, 20210.000.00―
Dec 31, 20200.000.00―
Dec 31, 20190.000.00―
Dec 31, 20180.000.00―
Dec 31, 20170.00――
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Related stocks
CompanyRevenue
MDGL1.28B
EXEL2.50B
IONS873.76M
ASND1.05B
BBIO945.54M
ROIV7.53M